Nitisinone (INN), also known as NTBC is a medication used to slow the effects of
hereditary tyrosinemia type 1. Since its first use for this indication in 1991, it has ...
ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase
inhibitor indicated as an adjunct to dietary restriction of tyrosine and ...
Description, Nitisinone is a synthetic reversible inhibitor of 4-
hydroxyphenylpyruvate dioxygenase. It is used in the treatment of hereditary
tyrosinemia type 1.
Nov 5, 2014 ... Nitisinone works by preventing the body from breaking down an amino acid
called tyrosine and by keeping other toxic substances from building ...
Nitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate
dioxygenase. It is used in the treatment of hereditary tyrosinemia type 1. It is sold
Drug information on Orfadin (nitisinone), includes drug pictures, side effects, drug
interactions, directions for use, symptoms of overdose, and what to avoid.
Drug information and side-effects for Orfadin (nitisinone)
Jul 5, 2011 ... Nitisinone is a potent inhibitor of the enzyme that catalyzes the formation of
homogentisic acid, and should be an even more logical treatment ...
Apr 20, 2013 ... Nitisinone for Type 1B Oculocutaneous Albinism. This study is ongoing, but not
recruiting participants. Sponsor: National Eye Institute (NEI).
Each capsule contains 2 mg nitisinone. For the full list of excipients, see section
6.1. 3. PHARMACEUTICAL FORM. Hard capsule. White, opaque capsules (6x16